YOR268C Antibody

What is YOR268C protein and what are the primary applications of its antibody?

YOR268C is a protein found in Saccharomyces cerevisiae (Baker's yeast). The antibody against this protein is primarily used in research applications such as Western Blotting (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) to detect and quantify YOR268C protein expression . As this antibody is polyclonal and raised against the recombinant full-length protein, it recognizes multiple epitopes, making it useful for various experimental conditions where protein conformation may be altered.

What are the optimal storage conditions for YOR268C Antibody?

The YOR268C Antibody should be stored at -20°C or -80°C upon receipt to maintain its activity. Repeated freeze-thaw cycles should be avoided as they can lead to protein denaturation and loss of antibody function . The antibody is supplied in liquid form containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . This formulation helps maintain stability during storage. For short-term use (within one month), storing aliquots at 4°C is acceptable, but long-term storage requires freezing temperatures.

How should I determine the optimal antibody concentration for my experiment?

Determining the optimal concentration requires titration experiments for each application. For Western blotting with YOR268C Antibody, begin with these methodological steps:

• Prepare a dilution series (1:500, 1:1000, 1:2000, 1:5000)

• Run identical protein samples on multiple gels

• Process blots identically except for primary antibody concentration

• Select the dilution that provides the clearest specific signal with minimal background

This methodological approach ensures experimental reproducibility and reliable detection of your target protein while conserving antibody resources .

How should I design control experiments when using YOR268C Antibody?

When designing experiments with YOR268C Antibody, implement the following control strategy to ensure valid interpretations:

• Positive control: Include lysate from wild-type S. cerevisiae known to express YOR268C

• Negative control: Use lysate from YOR268C knockout strains or non-yeast cells

• Loading control: Probe for a housekeeping protein like actin to normalize protein loading

• Antibody specificity control: Pre-adsorb antibody with recombinant YOR268C protein

• Secondary antibody control: Omit primary antibody to check for non-specific binding

This systematic approach follows experimental design principles where you manipulate your independent variable (presence/absence of YOR268C) while controlling for extraneous variables like protein loading, antibody specificity, and detection system performance . Document all control results alongside experimental data to demonstrate rigor and reproducibility.

What are the recommended lysate preparation methods for optimal YOR268C detection?

For effective YOR268C detection in yeast, implement this methodological protocol:

• Cell disruption: Use glass bead lysis in buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% Triton X-100

• Protease inhibition: Add a complete protease inhibitor cocktail immediately before lysis

• Denaturation conditions: Heat samples at 95°C for 5 minutes in reducing sample buffer

• Sample handling: Process samples immediately or store at -80°C to prevent degradation

This approach ensures complete extraction while preserving protein integrity, critical for antibody recognition since YOR268C Antibody is raised against the full-length recombinant protein . Avoid harsh detergents that might disrupt epitope structures, potentially reducing antibody binding efficiency.

How can I validate antibody specificity for YOR268C in my experimental system?

To validate YOR268C Antibody specificity, implement this comprehensive validation protocol:

• Genetic validation: Compare Western blot signals between wild-type and YOR268C deletion strains

• Competitive blocking: Pre-incubate antibody with excess recombinant YOR268C protein

• Mass spectrometry confirmation: Immunoprecipitate the target and verify identity by MS

• Size verification: Confirm the detected protein matches the predicted molecular weight

• Cross-reactivity assessment: Test against lysates from related yeast species

This methodical approach addresses a fundamental challenge in antibody research - ensuring the observed signal genuinely represents the intended target rather than cross-reactivity or non-specific binding . Document all validation results thoroughly as part of your experimental design process.

How can YOR268C Antibody be used in immunoprecipitation experiments?

For immunoprecipitation of YOR268C, follow this optimized protocol:

• Pre-clearing: Incubate cell lysate with protein A/G beads for 1 hour at 4°C

• Antibody binding: Add 2-5μg YOR268C Antibody to 500μg pre-cleared lysate, incubate overnight at 4°C

• Capture: Add fresh protein A/G beads, incubate for 2-4 hours at 4°C

• Washing: Perform 4 washes with decreasing salt concentration (500mM to 150mM NaCl)

• Elution: Use reducing sample buffer at 95°C for 5 minutes

This method leverages the polyclonal nature of YOR268C Antibody, which recognizes multiple epitopes, increasing the probability of capturing the native protein . The gradual reduction in salt concentration during washing helps maintain specific interactions while removing non-specific binding. Document all parameters thoroughly for experimental reproducibility.

What considerations are important when using YOR268C Antibody in co-immunoprecipitation studies?

When designing co-immunoprecipitation experiments to identify YOR268C interaction partners:

• Buffer optimization: Use mild lysis conditions (0.1-0.5% NP-40 or Digitonin) to preserve protein-protein interactions

• Crosslinking consideration: For transient interactions, use reversible crosslinkers like DSP (dithiobis(succinimidyl propionate))

• Control for specificity: Always run parallel IPs with non-specific IgG and lysate from YOR268C deletion strains

• Quantitative assessment: Use mass spectrometry-based approaches for unbiased identification of interaction partners

This methodological approach respects the delicate balance between maintaining protein complex integrity and achieving efficient extraction. The choice between native and crosslinking conditions should be informed by preliminary experiments assessing complex stability under different extraction conditions .

How can contradictory results from different detection methods using YOR268C Antibody be resolved?

When facing discrepancies between Western blot and ELISA results with YOR268C Antibody:

• Epitope accessibility analysis: Different detection methods expose different epitopes

  • Western blot denatures proteins, exposing linear epitopes

  • ELISA may maintain some tertiary structure, preserving conformational epitopes

• Methodological reconciliation approach:

  • Perform parallel analysis with multiple antibody dilutions

  • Test detection under both reducing and non-reducing conditions

  • Consider protein modifications that might affect epitope recognition

• Resolution strategy:

  • Use orthogonal detection methods (e.g., mass spectrometry) to validate conflicting results

  • Employ genetic controls (knockout/knockdown) to confirm specificity

  • Consider post-translational modifications that might affect antibody recognition

This systematic troubleshooting approach acknowledges that antibody-antigen interactions are influenced by experimental conditions, and apparent contradictions often reflect different aspects of protein biology rather than experimental errors .

What are the most common causes of false negative results with YOR268C Antibody?

When troubleshooting absent or weak signals when using YOR268C Antibody, consider these methodological remedies:

This structured analysis converts apparent experimental failures into informative data points. The most common issue with yeast proteins like YOR268C is often their relatively low abundance compared to mammalian systems, requiring optimization of both extraction and detection methods .

How can background issues in Western blots using YOR268C Antibody be reduced?

To optimize signal-to-noise ratio in Western blots with YOR268C Antibody:

• Blocking optimization: Test different blocking agents (5% BSA often performs better than milk for polyclonal antibodies)

• Washing protocol enhancement: Increase wash duration and volume (5 washes of 10 minutes each)

• Antibody dilution adjustment: Use higher dilutions (1:2000-1:5000) to reduce non-specific binding

• Buffer modification: Add 0.1% Tween-20 to antibody diluent to reduce hydrophobic interactions

• Filtration approach: Pre-adsorb the diluted antibody with membrane containing non-target proteins

This systematic approach addresses the polyclonal nature of YOR268C Antibody, which contains antibodies recognizing various epitopes with different affinities . Document optimization steps systematically to develop a reproducible protocol for your specific experimental system.

How should data from experiments using YOR268C Antibody be quantified and statistically analyzed?

For rigorous quantification of YOR268C detection:

• Image acquisition:

  • Capture images within the linear range of detection

  • Include a standard curve of recombinant protein when possible

  • Document all acquisition parameters (exposure time, gain settings)

• Quantification methodology:

  • Use integrated density measurements rather than peak intensity

  • Subtract local background for each band

  • Normalize to loading controls (e.g., actin, GAPDH)

• Statistical approach:

  • Perform experiments with at least three biological replicates

  • Use appropriate statistical tests based on data distribution (t-test for normal distribution, non-parametric tests otherwise)

  • Report effect sizes along with p-values

How can YOR268C Antibody be used in combination with genetic screening approaches?

To integrate YOR268C Antibody with genetic screens:

• Systematic genetic interaction mapping:

  • Screen YOR268C deletion strain against yeast deletion collection

  • Use Western blotting with YOR268C Antibody to validate protein absence in deletion strains

  • Quantify genetic interactions through growth rate measurements

• Suppressor screening methodology:

  • Identify suppressors of YOR268C deletion phenotypes

  • Validate mechanism through Western blot analysis of YOR268C levels in suppressor strains

  • Determine whether suppressors affect protein levels, modifications, or downstream pathways

• Integration with active learning approaches:

  • Use machine learning models to predict genetic interactions

  • Validate predictions with targeted Western blot analysis

  • Implement iterative experimental design that reduces required experiments by up to 35%

This integrated approach combines the specificity of antibody-based detection with the power of genetic screening, allowing for more efficient characterization of YOR268C function and interaction network .

What are the considerations for using YOR268C Antibody in immunofluorescence microscopy?

For successful immunofluorescence microscopy with YOR268C Antibody:

• Fixation optimization:

  • Test multiple fixation methods (formaldehyde, methanol, or combination)

  • Optimize fixation time (typically 10-30 minutes) to balance epitope preservation and cell permeabilization

• Antibody dilution determination:

  • Start with 1:100 dilution and titrate as needed

  • Incubate overnight at 4°C to maximize specific binding

• Specificity controls:

  • Include YOR268C deletion strains as negative controls

  • Perform peptide competition to confirm signal specificity

  • Use fluorescently tagged YOR268C as a positive control for localization pattern

• Signal amplification consideration:

  • For low abundance proteins, consider tyramide signal amplification

  • Use high-sensitivity cameras with extended exposure times

This detailed protocol acknowledges the challenges of detecting native yeast proteins by immunofluorescence while providing methodological solutions to overcome common obstacles .

How might advances in antibody development influence future YOR268C research?

Recent developments in antibody technology suggest several promising directions for YOR268C research:

• Next-generation antibody development:

  • Single-domain antibodies (nanobodies) offer improved access to sterically hindered epitopes

  • Dual-antibody approaches using anchor and inhibitor antibodies demonstrate improved specificity as seen in viral research

  • Active learning frameworks can reduce experimental costs by up to 35% while accelerating antibody development

• Enhanced detection systems:

  • New genotype-phenotype linked antibody screening methods compatible with NGS technology provide rapid identification of specific clones

  • Combination of multiple antibodies targeting different epitopes increases detection sensitivity

• Therapeutic implications:

  • While YOR268C Antibody is currently for research use only, similar approaches combining antibodies have shown therapeutic potential in other contexts

These emerging approaches represent significant methodological advances that could accelerate YOR268C research by providing more specific detection tools and expanding our understanding of protein function through enhanced detection capabilities .

What experimental design considerations are important for studies comparing wild-type and mutant forms of YOR268C?

When designing experiments to compare wild-type and mutant YOR268C:

• Mutation selection strategy:

  • Focus on conserved domains identified through sequence alignment

  • Target post-translational modification sites

  • Create systematic alanine-scanning mutations across the protein

• Expression system considerations:

  • Express proteins under native promoter to maintain physiological levels

  • Consider inducible systems for toxic mutations

  • Tag proteins consistently (N or C-terminal) across all variants

• Analysis pipeline:

  • Compare expression levels by Western blot using YOR268C Antibody

  • Assess subcellular localization through fractionation or microscopy

  • Evaluate functional changes through relevant phenotypic assays

• Control implementation:

  • Include isogenic wild-type strains grown under identical conditions

  • Process all samples in parallel to minimize technical variation

  • Blind the analysis phase to prevent confirmation bias